Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Santander – page 26

611 clinical trials in Santander, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Santander at a glance
611
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

611 trials in Santander

Open in trial search

Study on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Genentech Inc.

Study of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Resmetirom
  • Sponsor:Madrigal Pharmaceuticals Inc.

Crohn's disease

Not recruiting

Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ozanimod
  • Sponsor:Celgene International II S.a.r.l.

Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Study on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Systemic scleroderma

Not recruiting

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Fipaxalparant
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Study of benralizumab compared to placebo for treatment of patients with Hypereosinophilic Syndrome (HES)

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting

Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atuliflapon
  • Sponsor:AstraZeneca AB

Psoriatic arthropathy

Not recruiting

Study on Deucravacitinib and Apremilast for Patients with Active Psoriatic Arthritis New to Biologic Treatments or Previously on TNFα Inhibitors

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Rheumatoid arthritis

Not recruiting

Study Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Santander

What the registry says about research in the country

01 Oncology Research

Groundbreaking trials focusing on metastatic colorectal cancer, mantle cell lymphoma, and gastrointestinal cancers. Studies evaluate novel combination therapies and targeted treatments for improved patient outcomes.

  • Colorectal Cancer Treatment Innovations
  • Lymphoma Therapy Advances
  • Gastric Cancer Interventions

Multiple studies exploring new therapeutic approaches for various cancer types, including melanoma and lung cancer.

02 Respiratory Medicine

Clinical trials investigating treatments for chronic rhinosinusitis and uncontrolled asthma. Research focuses on developing innovative therapies and improving patient quality of life.

  • Asthma Management
  • Nasal Polyps Treatment
  • Respiratory Disease Control

Studies evaluate both established and novel therapeutic approaches for respiratory conditions.

03 Autoimmune Disorders

Innovative research examining treatments for psoriatic arthritis and Sjögren's disease. Trials focus on evaluating new biological therapies and their effectiveness in managing symptoms.

  • Arthritis Treatment Solutions
  • Autoimmune Disease Management
  • Biological Therapy Assessment

Comprehensive studies targeting various manifestations of autoimmune conditions.

04 Neurological Studies

Research investigating treatments for Alzheimer's disease and its connection with Down syndrome. Studies also include trials for multiple sclerosis and related neurological conditions.

  • Alzheimer's Disease Research
  • Multiple Sclerosis Treatments
  • Neurological Disease Management

Focused on developing effective treatments for complex neurological disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.